Blinatumomab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Blinatumomab and local guidelines before prescribing.

Bispecific T-cell engager

Mechanism

CD19/CD3 bispecific T-cell engager.

Uses

Relapsed or refractory B-cell acute lymphoblastic leukaemia.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Cytokine release syndrome, neurotoxicity, infections, neutropenia.

Interactions

Live vaccines contraindicated.

Contraindications and cautions

Active infection

Monitoring

FBC, neurology

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive; tocilizumab for CRS

Special advice

Continuous infusion with dexamethasone premedication; monitor neurology.

More from the textbook: uses, cautions and other points
Where it is discussed in the book